Potentiation of the anticonvulsant action of acetazolamide.
D000086:Acetazolamide / Q000494:pharmacology*; D000661:Amphetamine / Q000494:pharmacology*; D000818:Animals; D000927:Anticonvulsants / Q000494:pharmacology*; D002110:Caffeine / Q000494:pharmacology*; D003042:Cocaine / Q000494:pharmacology*; D003891:Desipramine / Q000494:pharmacology*; D004357:Drug Synergism; D004558:Electric Stimulation; D004597:Electroshock; D004809:Ephedrine / Q000494:pharmacology*; D006634:Histamine H1 Antagonists / Q000494:pharmacology; D007099:Imipramine / Q000494:pharmacology*; D007545:Isoproterenol / Q000494:pharmacology*; D008297:Male; D008680:Metaraminol / Q000494:pharmacology*; D051379:Mice; D009020:Morphine / Q000494:pharmacology; D010627:Phenethylamines / Q000494:pharmacology*; D000644:Quaternary Ammonium Compounds / Q000494:pharmacology*; D012640:Seizures / Q000188:drug therapy*; D013312:Stress, Physiological; D014191:Tranylcypromine / Q000494:pharmacology*; D014439:Tyramine / Q000494:pharmacology
D000927:Anticonvulsants; D006634:Histamine H1 Antagonists; D010627:Phenethylamines; D000644:Quaternary Ammonium Compounds; D014191:Tranylcypromine; D002110:Caffeine; D009020:Morphine; D008680:Metaraminol; D000661:Amphetamine; D004809:Ephedrine; D003042:Cocaine; D007545:Isoproterenol; D000086:Acetazolamide; D007099:Imipramine; D003891:Desipramine; D014439:Tyramine